Why Was a Bird Flu Vaccine That Works LESS Than Half of the Time Approved?

The flu pandemic that STILL hasn't come didn't stop a FDA advisory panel from voting unanimously to approve America's first bird flu vaccine yesterday. What's more, they called it "safe" and "effective," even though it works less than half the time!

In a clinical trial of adults who received the highest dose of the H5N1 bird vaccine, developed by Sanofi-Aventis, only 45 percent received any benefit. One analysis of the same study later found the effectiveness of the vaccine was slightly higher (54 percent) only after patients received the last of two-shot regimen.

If that alone doesn't worry you, here's what one panel member said about this H5N1 bird flu vaccine, developed by Sanofi-Aventis: I hope we never have to use it. Others called the vaccine better than nothing and a very tentative baby step.

Sounds like more of the same orchestrated fear to create stockpiles of a vaccine for a pandemic that hasn't come, taking your attention away from the fact that no one, including the current administration, knows where the money will come from to pay for all this "preparedness."

Just remember, you won't need a health-harming vaccine to protect your health from the flu, if you follow my recommendations for strengthening your immune system.